Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Delcath Systems, Inc.(DCTH) | 3,300,389 | 3,300,389 | 0 | $33.00M | $30.63M | 12.55% | -$2.38M |
| Xeris Biopharma Holdings Inc | 2,111,700 | 3,231,700 | +1,120,000 | $16.58M | $18.74M | 7.68% | +$2.17M |
| Fennec Pharmaceuticals Inc.(FENC) | 2,613,508 | 2,908,201 | +294,693 | $20.12M | $17.89M | 7.33% | -$2.24M |
| Savara Inc.(SVRA) | 3,403,721 | 3,203,721 | -200,000 | $20.52M | $17.49M | 7.17% | -$3.03M |
| Vaxcyte, Inc.(PCVX) | 0 | 290,000 | +290,000 | $0 | $16.85M | 6.90% | +$16.85M |
| EyePoint, Inc.(EYPT) | 690,000 | 1,036,737 | +346,737 | $12.61M | $13.36M | 5.48% | +$757.2K |
| X4 Pharmaceuticals, Inc.(XFOR) | 2,605,920 | 3,214,766 | +608,846 | $10.42M | $13.28M | 5.44% | +$2.85M |
| Vor Biopharma Inc.(VOR) | 0 | 700,000 | +700,000 | $0 | $12.49M | 5.12% | +$12.49M |
| MediWound Ltd.SHS NEW(MDWD) | 749,054 | 749,054 | 0 | $13.83M | $12.07M | 4.94% | -$1.76M |
| Verastem, Inc.(VSTM) | 1,788,475 | 2,138,475 | +350,000 | $13.81M | $11.33M | 4.64% | -$2.47M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 330,000 | +330,000 | $0 | $10.47M | 4.29% | +$10.47M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 0 | 923,057 | +923,057 | $0 | $8.79M | 3.60% | +$8.79M |
| Cybin D/B/A Helus Pharma(HELP) | 1,657,540 | 1,531,814 | -125,726 | $13.56M | $7.35M | 3.01% | -$6.21M |
| CG Oncology, Inc.(CGON) | 300,000 | 100,000 | -200,000 | $12.46M | $6.77M | 2.77% | -$5.69M |
| InspireMD, Inc.(NSPR) | 3,905,743 | 3,905,743 | 0 | $6.95M | $6.37M | 2.61% | -$585.9K |
| Atea Pharmaceuticals, Inc.(AVIR) | 0 | 1,171,855 | +1,171,855 | $0 | $6.30M | 2.58% | +$6.30M |
| Profound Medical Corp.(PROF) | 1,068,955 | 828,118 | -240,837 | $8.41M | $5.37M | 2.20% | -$3.05M |
| Viridian Therapeutics, Inc.(VRDN) | 450,000 | 250,401 | -199,599 | $14.00M | $4.90M | 2.01% | -$9.11M |
| PolyPid Ltd.(PYPD) | 696,556 | 597,926 | -98,630 | $3.02M | $2.62M | 1.07% | -$404.1K |
| Myomo, Inc.(MYO) | 3,839,772 | 3,847,272 | +7,500 | $3.49M | $2.60M | 1.06% | -$895.0K |
| Talphera, Inc.(TLPH) | 3,579,273 | 3,353,916 | -225,357 | $4.08M | $2.51M | 1.03% | -$1.58M |
| Ovid Therapeutics Inc.(OVID) | 0 | 1,107,994 | +1,107,994 | $0 | $2.46M | 1.01% | +$2.46M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 125,000 | +125,000 | $0 | $2.36M | 0.97% | +$2.36M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 730,488 | 443,763 | -286,725 | $2.12M | $1.84M | 0.75% | -$281.2K |
| Lipocine Inc.(LPCN) | 0 | 221,616 | +221,616 | $0 | $1.77M | 0.73% | +$1.77M |
| NeurAxis, Inc.(NRXS) | 286,138 | 286,138 | 0 | $1.04M | $1.69M | 0.69% | +$654.7K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 75,000 | +75,000 | $0 | $1.12M | 0.46% | +$1.12M |
| Annexon, Inc.(ANNX) | 0 | 200,000 | +200,000 | $0 | $1.11M | 0.45% | +$1.11M |
| Aquestive Therapeutics Inc | 0 | 250,000 | +250,000 | $0 | $1.04M | 0.43% | +$1.04M |
| Biofrontera Inc.(BFRI) | 1,140,764 | 1,163,962 | +23,198 | $650.2K | $941.6K | 0.39% | +$291.4K |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $1.04M | $813.0K | 0.33% | -$226.0K |
| Regentis Biomaterials Ltd.(RGNT) | 251,510 | 251,510 | 0 | $1.70M | $768.4K | 0.31% | -$926.8K |
| Astria Therapeutics Inc | 1,039,080 | 0 | -1,039,080 | $13.60M | $0 | — | -$13.60M |
| ArriVent BioPharma, Inc.(AVBP) | 215,871 | 0 | -215,871 | $4.34M | $0 | — | -$4.34M |
| Cytokinetics, Incorporated(CYTK) | 195,045 | 0 | -195,045 | $12.39M | $0 | — | -$12.39M |
| Fractyl Health, Inc.(GUTS) | 385,731 | 0 | -385,731 | $848.6K | $0 | — | -$848.6K |
| Mind Medicine Mindmed Inc | 750,000 | 0 | -750,000 | $10.04M | $0 | — | -$10.04M |
| Ocular Therapeutix, Inc.(OCUL) | 400,000 | 0 | -400,000 | $4.86M | $0 | — | -$4.86M |
| Replimune Group, Inc.(REPL) | 1,410,497 | 0 | -1,410,497 | $13.71M | $0 | — | -$13.71M |
| Trevi Therapeutics, Inc.(TRVI) | 100,000 | 0 | -100,000 | $1.25M | $0 | — | -$1.25M |